- Report
- August 2023
- 105 Pages
Global
From €3500EUR$4,178USD£3,118GBP
- Report
- January 2024
- 101 Pages
Global
From €3500EUR$4,178USD£3,118GBP
The Polypeptide Drug market is a subset of the Pharmaceuticals industry, focusing on the development and production of drugs made from polypeptides. Polypeptides are short chains of amino acids, which are the building blocks of proteins. These drugs are used to treat a variety of conditions, including cancer, diabetes, and autoimmune diseases. Polypeptide drugs are typically administered via injection, and are often used in combination with other drugs.
The Polypeptide Drug market is highly competitive, with many companies investing in research and development to create new drugs and treatments. Companies in the market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more